NCT06659965View on ClinicalTrials.gov

Intravenous Methocarbamol for Acute Pain After Spine Surgery

Active, not recruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Acute Post Operative PainPostsurgical Pain ManagementSpine SurgeryAcute Pain, PostoperativeMultimodal Analgesia
Interventions
DRUG

Intravenous Methocarbamol

At least 500 mg of intravenous methocarbamol administered within 2 hours after the end of elective spine surgery for acute postoperative pain management

Trial Locations (1)

77007-1708

Memorial Hermann Health System, Houston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER